IPP Bureau

Sigachi Industries gets ToR approval for API and specialty chemicals manufacturing facility in Andhra Pradesh
Sigachi Industries gets ToR approval for API and specialty chemicals manufacturing facility in Andhra Pradesh

By IPP Bureau - June 13, 2025

The project will be instrumental in enhancing the company's API manufacturing capacity and global reach

Cipla Health launches a new campaign for Cipladine with Neena Gupta as brand ambassador
Cipla Health launches a new campaign for Cipladine with Neena Gupta as brand ambassador

By IPP Bureau - June 13, 2025

Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films

IOL Chemicals and Pharmaceuticals bags EcoVadis silver medal
IOL Chemicals and Pharmaceuticals bags EcoVadis silver medal

By IPP Bureau - June 13, 2025

Ranks among the top 15% companies globally

USFDA inspection at the API manufacturing plant located in Mekaguda, Hyderabad
USFDA inspection at the API manufacturing plant located in Mekaguda, Hyderabad

By IPP Bureau - June 13, 2025

The company received 1 (One) observation in the Form-483

Sun Pharma appoints Kirti Ganorkar as the Managing Director
Sun Pharma appoints Kirti Ganorkar as the Managing Director

By IPP Bureau - June 13, 2025

Dilip Shanghvi to continue as the Executive Chairman of the Board

Zydus receives EIR for the API manufacturing facility at Ankleshwar and Dabhasa
Zydus receives EIR for the API manufacturing facility at Ankleshwar and Dabhasa

By IPP Bureau - June 12, 2025

Zydus receives EIR for the API manufacturing facility at Ankleshwar

Aayush Wellness to form subsidiary in Singapore to drive Southeast Asia expansion
Aayush Wellness to form subsidiary in Singapore to drive Southeast Asia expansion

By IPP Bureau - June 12, 2025

This strategic expansion marks a significant step in the company's global growth strategy

Boehringer Ingelheim and Eko Health collaborate to improve heart murmur detection in dogs
Boehringer Ingelheim and Eko Health collaborate to improve heart murmur detection in dogs

By IPP Bureau - June 12, 2025

The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms

FDA approves Merck’s enflonsia for prevention of RSV in infants
FDA approves Merck’s enflonsia for prevention of RSV in infants

By IPP Bureau - June 12, 2025

Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months

Biocon Foundation launches BioWISE Program to empower women in STEM
Biocon Foundation launches BioWISE Program to empower women in STEM

By IPP Bureau - June 11, 2025

25 women students to receive internship, training, and mentorship in Life Sciences segment

Lubrizol's polymer excipient Apisolex featured in Phase I candidate
Lubrizol's polymer excipient Apisolex featured in Phase I candidate

By IPP Bureau - June 11, 2025

The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold

Evertis selects Honeywell Aclar technology to enhance pharmaceutical packaging
Evertis selects Honeywell Aclar technology to enhance pharmaceutical packaging

By IPP Bureau - June 11, 2025

Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions

Brenntag Specialties acquires mcePharma to cater growing demand in Biopharma market
Brenntag Specialties acquires mcePharma to cater growing demand in Biopharma market

By IPP Bureau - June 11, 2025

The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market

Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases
Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases

By IPP Bureau - June 10, 2025

Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,

Glenmark Pharmaceuticals to launch DCGI-approved BRUKINSA in India for treatment of hematological malignancies
Glenmark Pharmaceuticals to launch DCGI-approved BRUKINSA in India for treatment of hematological malignancies

By IPP Bureau - June 10, 2025

Globally, BRUKINSA is approved in more than 70 countries

Latest Stories

Interviews

Packaging